Prevention and treatment of graft vessel disease after heart transplantation

Transplant Proc. 1995 Jun;27(3):1931-5.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Arteriosclerosis / prevention & control*
  • Arteriosclerosis / therapy*
  • Blood Component Removal
  • Cholesterol / blood
  • Double-Blind Method
  • Female
  • Graft Occlusion, Vascular / prevention & control*
  • Graft Occlusion, Vascular / therapy*
  • Graft vs Host Disease / prevention & control
  • Heart Transplantation / adverse effects*
  • Humans
  • Hypercholesterolemia / complications
  • Lovastatin / analogs & derivatives*
  • Lovastatin / therapeutic use
  • Male
  • Middle Aged
  • Oligopeptides / therapeutic use*
  • Peptides, Cyclic
  • Prospective Studies
  • Risk Factors
  • Simvastatin
  • Somatostatin / analogs & derivatives*
  • Somatostatin / therapeutic use
  • Tissue Donors

Substances

  • Oligopeptides
  • Peptides, Cyclic
  • lanreotide
  • Somatostatin
  • Cholesterol
  • Lovastatin
  • Simvastatin